Loading...
Autonomix Medical, Inc. Common Stock
AMIX•NASDAQ
HealthcareMedical - Devices
$1.48
$0.10(7.25%)
Autonomix Medical, Inc. Common Stock (AMIX) Stock Overview
Explore Autonomix Medical, Inc. Common Stock’s financial performance, market position, analyst ratings, and future outlook.
Revenue Growth
0.00%
Profit Growth
$-7.36
↓ 674.99%
EPS Growth
$-7.36
↓ 19081.82%
Operating Margin
0.00%
↓ 275.49%
ROE
-212.47%
↓ 674.99%
Dividend Yield
0.00%
Analyst Recommendations data is not available for AMIXAnalyst Recommendations details for AMIX are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.
Company Profile
Autonomix Medical, Inc., a development stage medical device development company, focuses on advancing technologies for sensing and treating disorders relating to the peripheral nervous system. Its technology platform includes a catheter-based microchip-enabled sensing array to detect and differentiate peripheral neural signals. The company was incorporated in 2014 and is based in The Woodlands, Texas.
CEO
Mr. Bradley Hauser
Employees
5
Headquarters
21 Waterway Avenue, The Woodlands
Founded
2024